BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26756273)

  • 21. Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms.
    Avramopoulos D; Fallin MD; Bassett SS
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):9-13. PubMed ID: 15389761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics of Psychosis in Alzheimer Disease.
    DeMichele-Sweet MA; Sweet RA
    Curr Genet Med Rep; 2014 Mar; 2(1):30-38. PubMed ID: 24883238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease.
    Borroni B; Agosti C; Archetti S; Costanzi C; Bonomi S; Ghianda D; Lenzi GL; Caimi L; Di Luca M; Padovani A
    Neurosci Lett; 2004 Nov; 370(2-3):127-9. PubMed ID: 15488308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.
    Wilkosz PA; Kodavali C; Weamer EA; Miyahara S; Lopez OL; Nimgaonkar VL; DeKosky ST; Sweet RA
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1054-62. PubMed ID: 17525976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heritability of psychosis in Alzheimer disease.
    Bacanu SA; Devlin B; Chowdari KV; DeKosky ST; Nimgaonkar VL; Sweet RA
    Am J Geriatr Psychiatry; 2005 Jul; 13(7):624-7. PubMed ID: 16009739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE.
    Bertram L; Lange C; Mullin K; Parkinson M; Hsiao M; Hogan MF; Schjeide BM; Hooli B; Divito J; Ionita I; Jiang H; Laird N; Moscarillo T; Ohlsen KL; Elliott K; Wang X; Hu-Lince D; Ryder M; Murphy A; Wagner SL; Blacker D; Becker KD; Tanzi RE
    Am J Hum Genet; 2008 Nov; 83(5):623-32. PubMed ID: 18976728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease.
    Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Duara R
    Am J Geriatr Psychiatry; 1999; 7(2):119-23. PubMed ID: 10322238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
    Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
    Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families.
    Barral S; Vardarajan BN; Reyes-Dumeyer D; Faber KM; Bird TD; Tsuang D; Bennett DA; Rosenberg R; Boeve BF; Graff-Radford NR; Goate AM; Farlow M; Lantigua R; Medrano MZ; Wang X; Kamboh MI; Barmada MM; Schaid DJ; Foroud TM; Weamer EA; Ottman R; Sweet RA; Mayeux R;
    Neurobiol Aging; 2015 Nov; 36(11):3116.e9-3116.e16. PubMed ID: 26359528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits.
    Legge SE; Jones HJ; Kendall KM; Pardiñas AF; Menzies G; Bracher-Smith M; Escott-Price V; Rees E; Davis KAS; Hotopf M; Savage JE; Posthuma D; Holmans P; Kirov G; Owen MJ; O'Donovan MC; Zammit S; Walters JTR
    JAMA Psychiatry; 2019 Dec; 76(12):1256-1265. PubMed ID: 31553412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses.
    Go RC; Perry RT; Wiener H; Bassett SS; Blacker D; Devlin B; Sweet RA
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):28-32. PubMed ID: 16082692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): association studies with psychosis in Alzheimer disease.
    Rocchi A; Micheli D; Ceravolo R; Manca ML; Tognoni G; Siciliano G; Murri L
    Genet Test; 2003; 7(4):309-14. PubMed ID: 15000807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haplotypes in cathechol-O-methyltransferase gene confer increased risk for psychosis in Alzheimer disease.
    Borroni B; Grassi M; Costanzi C; Zanetti M; Archetti S; Franzoni S; Caimi L; Padovani A
    Neurobiol Aging; 2007 Aug; 28(8):1231-8. PubMed ID: 16837108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
    Herold C; Hooli BV; Mullin K; Liu T; Roehr JT; Mattheisen M; Parrado AR; Bertram L; Lange C; Tanzi RE
    Mol Psychiatry; 2016 Nov; 21(11):1608-1612. PubMed ID: 26830138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease.
    Sweet RA; Nimgaonkar VL; Kamboh MI; Lopez OL; Zhang F; DeKosky ST
    Arch Neurol; 1998 Oct; 55(10):1335-40. PubMed ID: 9779662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease.
    Borroni B; Grassi M; Agosti C; Archetti S; Costanzi C; Cornali C; Caltagirone C; Caimi L; Di Luca M; Padovani A
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):343-51. PubMed ID: 16582043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.
    Sweet RA; Nimgaonkar VL; Devlin B; Jeste DV
    Mol Psychiatry; 2003 Apr; 8(4):383-92. PubMed ID: 12740595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.
    Pericak-Vance MA; Bass MP; Yamaoka LH; Gaskell PC; Scott WK; Terwedow HA; Menold MM; Conneally PM; Small GW; Vance JM; Saunders AM; Roses AD; Haines JL
    JAMA; 1997 Oct; 278(15):1237-41. PubMed ID: 9333264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD.
    Chang JB; Wang PN; Chen WT; Liu CY; Hong CJ; Lin KN; Liu TY; Chi CW; Liu HC
    Neurology; 2004 Sep; 63(6):1105-7. PubMed ID: 15452311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.
    Lyketsos CG; Baker L; Warren A; Steele C; Brandt J; Steinberg M; Kopunek S; Baker A
    J Neuropsychiatry Clin Neurosci; 1997; 9(1):64-7. PubMed ID: 9017530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.